Tagged Articles

migraine 8 articles

FDA approves medical device to treat migraine headaches

The Food and Drug Administration (FDA) has approved a novel new nerve-stimulating headband designed to treat and prevent migraine headaches. The device offers a new option for migraine sufferers who cannot tolerate migraine medications. The Cefaly device is a battery-powered plastic headband that is worn across the forehead. The band emits a low electrical current through an adhesive electrode to help stimulate nerves that trigger migraines. The headband is designed to be worn for up to 20 minutes a day in adult patients age 18 and older. The device was approved based on a 67-person study that showed those using ... Read More

FDA approves magnetic device for treating migraines preceded by auras

A new, magnetic device has been approved by the Food and Drug Administration (FDA) to relieve pain caused by migraine headaches proceeded by an aura. Migraines are a common type of headache that often occur with symptoms such as nausea, vomiting or sensitivity to light. In many people, a throbbing pain is felt only on one side of the head. Migraines can last anywhere between 4 to 72 hours if left untreated. About a third of migraine suffers experience warning symptoms, called an aura, before the actual headache begins. Auras produce strange symptoms such as dizziness, ringing in the ears, ... Read More

Mirena IUD side effect lawsuits expected to grow into hundreds

Sarah says her experience with Mirena IUD for birth control was so horrendous that she would never recommend the device to anyone. The mother of three says she felt pain the minute the intrauterine device was inserted. The pain got so bad she went to the emergency room where doctors told her she would have to have her IUD removed as soon as possible. The device had perforated her uterus and floated into her abdomen. She had to undergo surgery to remove it. It was a frightening experience, but one that is being reported more and more with the T-shaped, ... Read More

FDA approves first-ever migraine medicine skin patch

NuPathe is launching the first-ever patch to treat migraine headache, a product the device’s maker says is “game changing” to migraine sufferers. The Food and Drug Administration (FDA) gave NuPathe’s Zecuity the nod last week, and the company says it is currently focusing on securing commercial partners for the patch and hopes to have the patch on the market by the end of the year. Zecuity is a single-use, battery-powered patch that actively delivers the migraine medication sumatriptan through the skin. Sumatriptan has been on the market since 1991. It is administered in several forms including tablets, subcutaneous injection, and ... Read More

Dr. Oz show investigates risks, benefits of new diet drug

An investigational diet drug is getting media attention from celebrity doctor Dr. Oz as the “New Silver Bullet for Weight Loss,” but the Food and Drug Administration (FDA) has yet to approve the drug based on health concerns including heart problems and birth defects. The new drug, made by Vivus, is Qnexa, a combination of phentermine and topiramate. Phentermine is a stimulant that is FDA approved as a diet pill to aid in weight loss. It was once part of the wonder drug fen-phen, which was banned in 1997 for damaging heart valves. Tropiramate, also known by the brand Topamax, ... Read More

Anti-epileptic drugs can prevent migraines but may be dangerous to fetuses

A daily dose of anti-seizure drugs, including Topamax and Depakote, can help prevent recurrent migraine headaches, according to new preventative guidelines from the American Academy of Neurology. Researchers studied a once-daily dose of Topamax (topiramate) on patients who suffer from regular migraines and found that the medication decreased the frequency and often the severity of migraines by about 50 percent. The guidelines say that other preventative measures include certain beta-blockers, herbal products, and over-the-counter anti-inflammatories including ibuprofen and naproxen. Researchers speculate that the medications dampen the brain’s ability to generate the pain associated with the headache. Treating frequent migraines is ... Read More

Lawsuit claims Depakote during pregnancy caused serious birth defect

A mother has filed a lawsuit against the makers of the anti-seizure medication Depakote claiming that using the drug while she was pregnant caused her son to be born with a penile birth defect. The lawsuit claims that Abbott Laboratories knew the drug was dangerous to developing fetuses, but failed to adequately warn of the potential side effects when used by pregnant mothers. The defendant’s son was born in April 2010 with a birth defect known as hypospadias. Hypospadia is a birth defect in which the opening of the urethra develops on the underside of the penis. In severe cases, ... Read More

New migraine treatment to be available in US this month

A medication approved by the Food and Drug Administration (FDA) to treat migraine headaches is scheduled to become available in the United States this month. Cambia (diclofenac potassium for oral solution) was found to reduce migraine pain within 30 minutes, according to a study published in Cephalalgia, the international journal of headache. Data from the International Migraine Pain Assessment Clinical Trial (IMPACT) showed clinically significant improvement following treatment with Cambia in all four FDA-mandated co-primary endpoints for migraine – pain, nausea, potophobia and ponophobia. “Our study demonstrates that diclofenac potassium for oral solution relieved the pain and reduced the other ... Read More